Cholesteryl Ester Transfer Protein and Mortality in Patients Undergoing Coronary Angiography | Zendy

Andreas Ritsch | Zendy; Hubert Scharnagl | Zendy; Kathrin Eller | Zendy; Ivan Tancevski | Zendy; Kristina Duwensee | Zendy; Egon Demetz | Zendy; A. Sandhofer | Zendy; Bernhard O. Boehm | Zendy; Bernhard R. Winkelmann | Zendy; Josef R. Patsch | Zendy; Winfried März | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cholesteryl Ester Transfer Protein and Mortality in Patients Undergoing Coronary Angiography

Author(s) -

Andreas Ritsch,

Hubert Scharnagl,

Kathrin Eller,

Ivan Tancevski,

Kristina Duwensee,

Egon Demetz,

A. Sandhofer,

Bernhard O. Boehm,

Bernhard R. Winkelmann,

Josef R. Patsch,

Winfried März

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.875013

Subject(s) - medicine , cholesterylester transfer protein , quartile , cardiology , coronary artery disease , hazard ratio , diabetes mellitus , lipoprotein , cholesterol , endocrinology , confidence interval

The role of cholesteryl ester transfer protein (CETP) in the development of atherosclerosis is still open to debate. In the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial, inhibition of CETP in patients with high cardiovascular risk was associated with increased high-density lipoprotein levels but increased risk of cardiovascular morbidity and mortality. In this report, we present a prospective observational study of patients referred to coronary angiography in which CETP was examined in relation to morbidity and mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research